T-box transcription factor TBX1, targeted by microRNA-6727-5p, inhibits cell growth and enhances cisplatin chemosensitivity of cervical cancer cells through AKT and MAPK pathways

References

• Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424.
   PubMed Web of Science ®Google Scholar
• Cohen PA, Jhingran A, Oaknin A, et al. Cervical cancer. Lancet. 2019;393(10167):169–182.
   Web of Science ®Google Scholar
• Zhao F, Qiao Y. Cervical cancer prevention in China: a key to cancer control. Lancet. 2019;393(10175):969–970.
   Web of Science ®Google Scholar
• Duenas-Gonzalez A, Gonzalez-Fierro A. Pharmacodynamics of current and emerging treatments for cervical cancer. Expert Opin Drug Metab Toxicol. 2019;15(8):671–682.
   PubMed Web of Science ®Google Scholar
• Feng CH, Mell LK, Sharabi AB, et al. Immunotherapy with radiotherapy and chemoradiotherapy for cervical cancer. Semin Radiat Oncol. 2020;30(4):273–280.
   PubMed Web of Science ®Google Scholar
• Vale CL, Tierney JF, Davidson SE, et al. Substantial improvement in UK cervical cancer survival with chemoradiotherapy: results of a royal college of radiologists’ audit. Clin Oncol (R Coll Radiol). 2010;22(7):590–601.
   Web of Science ®Google Scholar
• Feng Y, Zou W, Hu C, et al. Modulation of CASC2/miR-21/PTEN pathway sensitizes cervical cancer to cisplatin. Arch Biochem Biophys. 2017;623-624:20–30.
   PubMed Web of Science ®Google Scholar
• Papaioannou VE. The T-box gene family: emerging roles in development, stem cells and cancer. Development. 2014;141(20):3819–3833.
   PubMed Web of Science ®Google Scholar
• McDonald-McGinn DM, Sullivan KE, Marino B, et al. 22q11.2 deletion syndrome. Nature reviews. Disease primers. 2015;1:15071.
   PubMed Web of Science ®Google Scholar
• Scambler PJ. 22q11 deletion syndrome: a role for TBX1 in pharyngeal and cardiovascular development. Pediatr Cardiol. 2010;31(3):378–390.
   PubMed Web of Science ®Google Scholar
• Chen M, Yang YS, Shih JC, et al. Microdeletions/duplications involving TBX1 gene in fetuses with conotruncal heart defects which are negative for 22q11.2 deletion on fluorescence in-situ hybridization. Ultrasound Obstetrics Gynecol. 2014;43(4):396–403.
   PubMed Web of Science ®Google Scholar
• Jiang H, Li L, Li-Ling J, et al. Increased Tbx1 expression may play a role via TGFβ-Smad2/3 signaling pathway in acute kidney injury induced by gentamicin. Int J Clin Exp Pathol. 2014;7(4):1595–1605.
   PubMed Web of Science ®Google Scholar
• Li D, Gordon CT, Oufadem M, et al. Heterozygous mutations in TBX1 as a cause of isolated hypoparathyroidism. J Clin Endocrinol Metab. 2018;103(11):4023–4032.
   PubMed Web of Science ®Google Scholar
• Verdelli C, Avagliano L, Guarnieri V, et al. Expression, function, and regulation of the embryonic transcription factor TBX1 in parathyroid tumors. Lab Invest. 2017;97(12):1488–1499.
   PubMed Web of Science ®Google Scholar
• Wang N, Li Y, Wei J, et al. TBX1 functions as a tumor suppressor in thyroid cancer through inhibiting the activities of the PI3K/AKT and MAPK/ERK pathways. Thyroid. 2019;29(3):378–394.
   PubMed Web of Science ®Google Scholar
• Caprio C, Varricchio S, Bilio M, et al. TBX1 and basal cell carcinoma: expression and Interactions with Gli2 and Dvl2 signaling. Int J Mol Sci. 2020;21(2):2.
   Web of Science ®Google Scholar
• Sun H, Jiang P. MicroRNA-451a acts as tumor suppressor in cutaneous basal cell carcinoma. Mol Genet Genomic Med. 2018;6(6):1001–1009.
   PubMed Web of Science ®Google Scholar
• Trempus CS, Wei SJ, Humble MM, et al. A novel role for the T-box transcription factor Tbx1 as a negative regulator of tumor cell growth in mice. Mol Carcinog. 2011;50(12):981–991.
   PubMed Web of Science ®Google Scholar
• Deng B, Zhang Y, Zhang S, et al. MicroRNA-142-3p inhibits cell proliferation and invasion of cervical cancer cells by targeting FZD7. Tumour Biol. 2015;36(10):8065–8073.
   PubMedGoogle Scholar
• Li C, Ding D, Gao Y, et al. MicroRNA-3651 promotes colorectal cancer cell proliferation through directly repressing T-box transcription factor 1. Int J Mol Med. 2020;45(3):956–966.
   PubMed Web of Science ®Google Scholar
• Zhang F, Liu J, Xie BB. Downregulation of microRNA-205 inhibits cell invasion and angiogenesis of cervical cancer through TSLC1-mediated Akt signaling pathway. J Cell Physiol. 2019;234(10):18626–18638.
   PubMed Web of Science ®Google Scholar
• Liu H, Pei G, Song M, et al. Influence of hsa-miR-6727-5p on the proliferation, apoptosis, invasion and migration of caski, hela and SiHa cervical cancer cells. 2017;22(4):973–978. Journal of B.U.ON.: official journal of the Balkan Union of Oncology .
   PubMed Web of Science ®Google Scholar
• Hu HZ, Yang YB, Xu XD, et al. Oridonin induces apoptosis via PI3K/Akt pathway in cervical carcinoma HeLa cell line. Acta Pharmacol Sin. 2007;28(11):1819–1826.
   PubMed Web of Science ®Google Scholar
• Liu Y, Xing H, Weng D, et al. Inhibition of Akt signaling by SN-38 induces apoptosis in cervical cancer. Cancer Lett. 2009;274(1):47–53.
   PubMed Web of Science ®Google Scholar
• Prasad SB, Yadav SS, Das M, et al. PI3K/AKT pathway-mediated regulation of p27(Kip1) is associated with cell cycle arrest and apoptosis in cervical cancer. Cell Oncol (Dordr). 2015;38(3):215–225.
   PubMed Web of Science ®Google Scholar
• Qi YL, Li Y, Man XX, et al. CXCL3 overexpression promotes the tumorigenic potential of uterine cervical cancer cells via the MAPK/ERK pathway. J Cell Physiol. 2020;235(5):4756–4765.
   PubMed Web of Science ®Google Scholar
• Wang Q, Yan SP, Chu DX, et al. Silencing of long non-coding RNA RP1-93H18.6 acts as a tumor suppressor in cervical cancer through the blockade of the PI3K/Akt axis. Molecular therapy. Nucleic acids. 2020;19:304–317.
   Web of Science ®Google Scholar
• Chandrashekar DS, Bashel B, Balasubramanya SAH, et al. UALCAN: a portal for facilitating tumor subgroup gene expression and survival analyses. Neoplasia. 2017;19(8):649–658.
   PubMed Web of Science ®Google Scholar
• Song Y, Jin D, Chen J, et al. Identification of an immune-related long non-coding RNA signature and nomogram as prognostic target for muscle-invasive bladder cancer. Aging (Albany NY). 2020;12(12):12051–12073.
   PubMedGoogle Scholar
• Gagliardi PA, Puliafito A, Primo L. PDK1: at the crossroad of cancer signaling pathways. Semin Cancer Biol. 2018;48:27–35.
   PubMed Web of Science ®Google Scholar
• Kim HK, Bhattarai KR, Junjappa RP, et al. TMBIM6/BI-1 contributes to cancer progression through assembly with mTORC2 and AKT activation. Nat Commun. 2020;11(1):4012.
   PubMed Web of Science ®Google Scholar
• Che Y, Li Y, Zheng F, et al. TRIP4 promotes tumor growth and metastasis and regulates radiosensitivity of cervical cancer by activating MAPK, PI3K/AKT, and hTERT signaling. Cancer Lett. 2019;452:1–13.
   PubMed Web of Science ®Google Scholar
• Li YJ, Wang Y, Wang YY. MicroRNA-99b suppresses human cervical cancer cell activity by inhibiting the PI3K/AKT/mTOR signaling pathway. J Cell Physiol. 2019;234(6):9577–9591.
   PubMed Web of Science ®Google Scholar